Podcast Episodes
Back to SearchPersonalizing BTK Inhibitor Therapy in CLL: from treatment selection to long-term management
Episode 355
This VJHemOnc podcast explores how BTK inhibitor therapy can be personalized for patients with chronic lymphocytic leukemia (CLL), considering disea…
12 hours ago
Using BTK inhibitors in lymphoma: practical considerations for community physicians
Episode 354
This episode of the VJHemOnc podcast, featuring Manali Kamdar, MD, University of Colorado Cancer Center, Denver, CO, focuses on the practical use of …
3 weeks ago
AAV gene therapy in hemophilia: progress, challenges and what comes next
Episode 353
This VJHemOnc podcast explores the evolving role of gene therapy in hemophilia, focusing on the challenges of AAV-based approaches and the developme…
4 weeks, 1 day ago
Clinical considerations in MCL management: frailty assessment, the multidisciplinary team & managing the use of BTKis
Episode 352
This VJHemOnc podcast explores the evolving management of mantle cell lymphoma (MCL), from assessing patient fitness to sequencing therapy after BTK …
1 month ago
Sequencing therapies in multiple myeloma: navigating an expanding treatment landscape
Episode 351
This VJHemOnc podcast explores the evolving treatment landscape in multiple myeloma, focusing on treatment selection and sequencing across the diseas…
1 month, 1 week ago
The evolving treatment landscape in ALL: the growing role of immunotherapy and reduced reliance on chemotherapy
Episode 350
There has been a significant shift in the treatment of acute lymphoblastic leukemia (ALL), driven by the emergence of novel immunotherapies. In this …
1 month, 2 weeks ago
Precision medicine in MDS: tailoring treatment through molecular profiling
Episode 349
This VJHemOnc podcast explores how precision medicine is reshaping the management of myelodysplastic syndromes (MDS). Alex Bataller, MD, PhD, The Uni…
1 month, 3 weeks ago
The current and future role of BTK inhibitors across non-Hodgkin lymphoma subtypes
Episode 348
This episode of the VJHemOnc podcast explores the current and future role of BTK inhibition across several non-Hodgkin lymphoma (NHL) subtypes.
Firs…
2 months, 1 week ago
The diagnosis and management of hematologic malignancies during pregnancy
Episode 347
In this episode of the VJHemOnc podcast, Daan Dierickx, MD, PhD, KU Leuven and University Hospitals Leuven, Leuven, Belgium, shares insight into the …
2 months, 2 weeks ago
Hodgkin lymphoma in 2026: frontline strategies, ctDNA, and treatment after relapse
Episode 346
This VJHemOnc podcast explores the latest advances in Hodgkin lymphoma, from evolving frontline treatment strategies to emerging approaches in relaps…
2 months, 3 weeks ago